SZSE Ticker: 002900

Harbin Medisan Pharmaceutical Co., Ltd.

哈尔滨三联药业股份有限公司

哈三联

MEDISAN

Listing Date: 2017-09-22

Board: SME

Industry Classification: Manufacturing

How did Fuerjia get a surprise dividend of 1 billion yuan before IPO and only 1 design patent under the strict supervision of medical aesthetics? Internet channel Rongyi Information Network

How did Fuerjia get a surprise dividend of 1 billion yuan before IPO and only 1 design patent under the strict supervision of medical aesthetics? Internet channel Rongyi Information Network

Harbin Sanlian invested 3.51 million in four months and made a huge profit of 566 million in the main business, deducted non-profits for two consecutive years, and compressed R&D expenses.

What are the skin and beauty concept stocks in 2022? List and ranking of leading stocks in skin and beauty (stock code)

How did Fuerjia get a surprise dividend of 1 billion yuan before IPO and only 1 design patent under the strict supervision of medical aesthetics? Internet channel Rongyi Information Network

During the reporting period, Fuerjia’s IPO comprehensive gross profit margin exceeded 75%. The average purchase cost per box of facial mask is ten yuan and the highest selling price is one hundred yuan. Internet channel Rongyi Information Network

During the reporting period, Fuerjia’s IPO comprehensive gross profit margin exceeded 75%. The average purchase cost per box of facial mask is ten yuan and the highest selling price is one hundred yuan. Internet channel Rongyi Information Network

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks will increase in revenue and net profit, and BeiGene will become the "loss king"-Stock Channel-Hexun.com

Over 60% of pharmaceutical companies will see net profit growth in 2021, and the pace of approval and listing of innovative drugs will continue to accelerate_Shenzhen Hotline

Over 60% of pharmaceutical companies will grow in net profit in 2021, and the pace of approval and listing of innovative drugs will continue to accelerate

First quarter results plummeted! "Glove Mao" Inke Medical thwarted the concept of hepatitis but quietly rose! Shuangcheng Pharmaceutical 4 consecutive boards_ Oriental Fortune Net

2,576 companies announced annual dividend plans_ Oriental Fortune Net

Medical beauty concept stocks fluctuated lower

Investment hedging guide: The latest German clinical study shows that Pfizer’s mRNA vaccine may cause autoimmune hepatitis, Yongan Futures’ first-quarter net profit fell by 90.1% year-on-year, and Raycus’ first-quarter net profit fell by 81% year-on-year

Southern China Securities 500 Information Technology ETF Link A Net Value Falls 3.17% Gains_Sina Finance_Sina Network

Seed industry concept plummeted, 2 stocks plummeted- CFi.CN Zhongcai Network

Pork concept leads the decline CFi.CN

Harbin Sanlian: Harbin Sanlian has passed the new version of veterinary drug GMP certification and obtained the GMP certificate on February 7, 2022

Harbin Sanlian: Harbin Sanlian has passed the new version of veterinary drug GMP certification and obtained the GMP certificate on February 7, 2022.

Harbin Sanlian: Harbin Sanlian has passed the new version of veterinary drug GMP certification, and obtained the GMP certificate on February 7, 2022

Want to see more data? Registered subscribers can see all the data.